← Leaderboards
Daniel L Gustafson
University Of Colorado Denver
$3,654,915
Attributed
$4,912,297
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $640K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,912,297 · 5
By mechanism
R01$3,447,658 · 2
P30$1,111,408 · 2
K01$353,231 · 1
Top collaborators
- Andrew M Thorburn5 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Antonio Jimeno$15,496,689
- Mary Elaine Reyland$13,618,689
- Kirsten H Limesand$6,799,601
- Sana D Karam$9,495,305
- Sue Kinnamon$17,923,672
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BasePharmaceutical PreparationsPharmacokinetic ModelDoseMalignant NeoplasmsResearch PersonnelPharmacologyMethodologyDesignMemberClinical ResearchColoradoAnimalsConsultationsChargeLiquid SubstanceProceduresDetectionCancer ControlBiologicalCancer CenterAnalytical MethodCancer Center Support GrantQuality Assurance
Grant awards (24)
Therapeutic targeting of autophagy-dependent cancer$446,818
R01 · FY2019 · CA
Therapeutic targeting of autophagy-dependent cancer$591,854
R01 · FY2018 · CA
Therapeutic targeting of autophagy-dependent cancer$491,156
R01 · FY2017 · CA
Therapeutic targeting of autophagy-dependent cancer$482,625
R01 · FY2016 · CA
PHARMACOLOGY CORE$137,157
P30 · FY2016 · CA · contact PI
Therapeutic targeting of autophagy-dependent cancer$502,312
R01 · FY2015 · CA
PHARMACOLOGY CORE$137,656
P30 · FY2015 · CA · contact PI
PHARMACOLOGY CORE$133,250
P30 · FY2014 · CA · contact PI
PHARMACOLOGY CORE$131,521
P30 · FY2013 · CA · contact PI
PHARMACOLOGY CORE$961
P30 · FY2013 · CA · contact PI
PHARMACOLOGY CORE$137,271
P30 · FY2012 · CA · contact PI
PHARMACOLOGY CORE$95,145
P30 · FY2010 · CA · contact PI
PHARMACOLOGY CORE$100,651
P30 · FY2009 · CA · contact PI
Dual Compartmental Targeting of Cancer$224,150
R01 · FY2008 · CA · contact PI
PHARMACOLOGY CORE$94,648
P30 · FY2008 · CA · contact PI
Dual Compartmental Targeting of Cancer$222,235
R01 · FY2007 · CA · contact PI
PHARMACOLOGY CORE$92,076
P30 · FY2007 · CA · contact PI
Dual Compartmental Targeting of Cancer$5,861
R01 · FY2007 · CA · contact PI
Dual Compartmental Targeting of Cancer$237,525
R01 · FY2006 · CA · contact PI
PHARMACOLOGY CORE$51,072
P30 · FY2006 · CA · contact PI
Dual Compartmental Targeting of Cancer$243,122
R01 · FY2005 · CA
PREDICTIVE MODELS FOR COMBINATION CANCER CHEMOTHERAPY$120,260
K01 · FY2002 · CA
PREDICTIVE MODELS FOR COMBINATION CANCER CHEMOTHERAPY$117,711
K01 · FY2001 · CA
PREDICTIVE MODELS FOR COMBINATION CANCER CHEMOTHERAPY$115,260
K01 · FY2000 · CA